Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2021 | 03-2018 | 03-2007 | 03-2006 | |
| Sales | 23,795 | 0 | 0 | 0 |
| Cost of Goods | 2,057 | N/A | N/A | N/A |
| Gross Profit | 21,738 | N/A | N/A | N/A |
| Operating Expenses | 1,092,693 | 0 | 0 | 0 |
| Operating Income | -1,070,898 | N/A | N/A | N/A |
| Other Income | 172,351 | 0 | 0 | 0 |
| Pre-tax Income | -898,547 | 0 | 0 | 0 |
| Income Tax | 1,686 | N/A | N/A | N/A |
| Net Income Continuous | -900,233 | N/A | N/A | N/A |
| Minority Interests | -90,999 | N/A | N/A | N/A |
| Net Income | $-809,234 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -1.28 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.43 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.28 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.43 | N/A | N/A | N/A |
| EBITDA(a) | $-1,070,898 | $N/A | $N/A | $N/A |